Indira Guleria PhD, D(ABHI), CABP(H)

Dr. Indira Guleria is an Immunologist and Immunogenetics with over 20 years of experience in the field. Dr. Guleria is Director of Histocompatibility and Immunogenetics (HLA) at BIDMC. Dr. Guleria’s primary research involves studying the mechanisms of transplant tolerance, and the role of various costimulatory molecules involved. She is also interested in deciphering the mechanisms of platelet refractoriness including the role of HLA antibodies and HLA epitopes in this process. Dr. Guleria has also been a leader in providing education to fellows, residents, and faculty and has helped develop professional educational programs that aim to enhance knowledge, skill, abilities, and competency of the participants across the hospital and beyond. She currently serves as chair of ASHI Education Initiatives committee, co-leader of AABB’s Current and Emerging Technologies Committee and a member of the Cellular Therapies Section Coordinating Committee.